CHRS SBC to Revenue

Coherus Oncology Inc · SBC to Revenue

CHRS logo

CHRS SBC to Revenue

Current (TTM)42.28%
CHRS SBC/Revenue (23.33% → 42.28%)
High-resolution chart · PNG

CHRS sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
40.2305%
10.4143%
16.7584%
24.0412%
15.7292%
8.0198%
9.4338%
2,236.3111%
2,317.8021%
14.4241%
55.6606%
35.5623%
74.3366%
23.3281%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.